Hubei Guangji Pharmaceutical Balance Sheet Health
Financial Health criteria checks 1/6
Hubei Guangji Pharmaceutical has a total shareholder equity of CN¥1.2B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 121.4%. Its total assets and total liabilities are CN¥3.1B and CN¥1.9B respectively.
Key information
121.4%
Debt to equity ratio
CN¥1.48b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥426.50m |
| Equity | CN¥1.22b |
| Total liabilities | CN¥1.89b |
| Total assets | CN¥3.11b |
Recent financial health updates
No updates
Recent updates
Subdued Growth No Barrier To Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Price
Oct 28
Benign Growth For Hubei Guangji Pharmaceutical Co., Ltd. (SZSE:000952) Underpins Stock's 30% Plummet
Jun 07There's No Escaping Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Muted Revenues Despite A 28% Share Price Rise
Mar 08Financial Position Analysis
Short Term Liabilities: 000952's short term assets (CN¥1.2B) do not cover its short term liabilities (CN¥1.2B).
Long Term Liabilities: 000952's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥719.6M).
Debt to Equity History and Analysis
Debt Level: 000952's net debt to equity ratio (86.3%) is considered high.
Reducing Debt: 000952's debt to equity ratio has increased from 58.3% to 121.4% over the past 5 years.
Debt Coverage: 000952's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 000952's interest payments on its debt are well covered by EBIT.